Ключевые слова
Аннотация
Antifosfolipid sindromi (AFS) homiladorlik davrida gemostaz tizimining buzilishlari bilan kechadigan autoimmun patologiya hisoblanadi. Ushbu sindromda antifosfolipid antitanachalar trombozga moyillikni kuchaytirib, platsenta ichki qon aylanishini izdan chiqaradi. Natijada fetoplatsentar qon aylanish buzilib, homilaning gipoksiyasi, intrauterin o‘sishdan ortda qolishi, erta homila tushishi va preeklampsiya xavfi ortadi. AFS mavjud homiladorlarda gemostaz monitoringi, antikoagulyant va antiplatelet terapiya qo‘llash orqali trombotik asoratlarning oldini olish, shuningdek, platsentar qon oqimini yaxshilash muhim ahamiyat kasb etadi. Shu tarzda to‘g‘ri tashxis va davolash homilaning sog‘lom rivojlanishi va ona salomatligini ta’minlashga xizmat qiladi.
Библиографические ссылки
Namozov, E. (2024). KЛИНИКО-МОРФОЛОГИЧЕСКИЕ ФОРМЫ РАКА МОЧЕВОГО ПУЗЫРЯ. Modern Science and Research, 3(12), 911-914.
Namozov, E. (2024). OПУХОЛИ ПОЧЕК. Modern Science and Research, 3(11), 884-886.
Namozov, E. (2024). PRECANCEROUS DISEASES OF THE STOMACH. Modern Science and Research, 3(10), 506-508.
Namozov, E. (2025). CLINICAL COURSE AND METHODS OF TREATMENT OF MALIGNANT TUMOR OF THE SIGMOID COLON. Modern Science and Research, 4(1), 651-655.
Jo’rayeva, G. (2024). COMBINATION OF DIABETES AND METABOLIC SYNDROME. Modern Science and Research, 3(12), 691-696.
Jo’rayeva, G. (2025). RISK FACTORS FOR THE DEVELOPMENT OF CLIMACTERIC DISORDERS IN WOMEN WITH THE METABOLIC SYNDROME. Modern Science and Research, 4(1), 1090-1092.